Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Peer Christiansen"'
Autor:
Søren Feddersen, Cathrine Bredal Lythjohan, Thomas P. Ahern, Deirdre Cronin-Fenton, Anders Kjærsgaard, Peer Christiansen, Timothy L. Lash, Bent Ejlertsen, Per Damkier, Stephen Hamilton-Dutoit
Publikováno v:
Ahern, T P, Damkier, P, Feddersen, S, Kjærsgaard, A, Lash, T L, Hamilton-Dutoit, S, Lythjohan, C B, Ejlertsen, B, Christiansen, P M & Cronin-Fenton, D P 2020, ' Predictive pharmacogenetic biomarkers for breast cancer recurrence prevention by simvastatin ', Acta Oncologica, vol. 59, no. 9, pp. 1009-1015 . https://doi.org/10.1080/0284186X.2020.1759820
Acta Oncol
Acta Oncol
Background: Statins treat hyperlipidemia and prevent cardiovascular morbidity and mortality. Evidence suggests that they also have anti-neoplastic activity. Several studies show a reduced rate of breast cancer recurrence among lipophilic statin users
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7599fe9f231f4b44d03ae47875a0159e
https://pure.au.dk/portal/da/publications/predictive-pharmacogenetic-biomarkers-for-breast-cancer-recurrence-prevention-by-simvastatin(7c8b40dd-4ca1-411d-acd7-29ae79244b9e).html
https://pure.au.dk/portal/da/publications/predictive-pharmacogenetic-biomarkers-for-breast-cancer-recurrence-prevention-by-simvastatin(7c8b40dd-4ca1-411d-acd7-29ae79244b9e).html
Autor:
Birgitte Vrou Offersen, Lisbet Rosenkrantz Hölmich, Anne Bodilsen, Peer Christiansen, Rob A. E. M. Tollenaar, M.B. Jensen, E. Heeg, Bent Ejlertsen, Marc A.M. Mureau, Anne-Vibeke Lænkholm
Publikováno v:
Heeg, E, Jensen, M B, Holmich, L R, Bodilsen, A, Tollenaar, R A E M, Laenkholm, A V, Offersen, B V, Ejlertsen, B, Mureau, M A M & Christiansen, P M 2020, ' Rates of re-excision and conversion to mastectomy after breast-conserving surgery with or without oncoplastic surgery : a nationwide population-based study ', British Journal of Surgery, vol. 107, no. 13, pp. 1762-1772 . https://doi.org/10.1002/bjs.11838
British Journal of Surgery, 107(13), 1762-1772. John Wiley & Sons Ltd.
The British Journal of Surgery
British Journal of Surgery, 107(13), 1762-1772. WILEY
British Journal of Surgery, 107(13), 1762-1772. Oxford University Press
Heeg, E, Jensen, M B, Hölmich, L R, Bodilsen, A, Tollenaar, R A E M, Lænkholm, A V, Offersen, B V, Ejlertsen, B, Mureau, M A M & Christiansen, P M 2020, ' Rates of re-excision and conversion to mastectomy after breast-conserving surgery with or without oncoplastic surgery : a nationwide population-based study ', British Journal of Surgery, vol. 107, no. 13, pp. 1762-1772 . https://doi.org/10.1002/bjs.11838
British Journal of Surgery, 107(13), 1762-1772. John Wiley & Sons Ltd.
The British Journal of Surgery
British Journal of Surgery, 107(13), 1762-1772. WILEY
British Journal of Surgery, 107(13), 1762-1772. Oxford University Press
Heeg, E, Jensen, M B, Hölmich, L R, Bodilsen, A, Tollenaar, R A E M, Lænkholm, A V, Offersen, B V, Ejlertsen, B, Mureau, M A M & Christiansen, P M 2020, ' Rates of re-excision and conversion to mastectomy after breast-conserving surgery with or without oncoplastic surgery : a nationwide population-based study ', British Journal of Surgery, vol. 107, no. 13, pp. 1762-1772 . https://doi.org/10.1002/bjs.11838
Background There is no consensus regarding the impact of oncoplastic surgery (OPS) on rates of re‐excision and conversion to mastectomy following breast‐conserving surgery (BCS). Here these two outcomes after BCS and OPS were compared in a nation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::289f28edb36b5ff5cd069f9ee69bd323
https://hdl.handle.net/1887/3195175
https://hdl.handle.net/1887/3195175
Autor:
M.T.F.D. Vrancken Peeters, R.A.E.M. Tollenaar, E. Heeg, M.B. Jensen, Peer Christiansen, Bent Ejlertsen, Marc A.M. Mureau
Publikováno v:
Breast Cancer Research and Treatment, 182(3), 709-718. SPRINGER
Breast Cancer Research and Treatment
Heeg, E, Jensen, M B, Mureau, M A M, Ejlertsen, B, Tollenaar, R A E M, Christiansen, P M & Vrancken Peeters, M T F D 2020, ' Breast-contour preserving procedures for early-stage breast cancer : a population-based study of the trends, variation in practice and predictive characteristics in Denmark and the Netherlands ', Breast Cancer Research and Treatment, vol. 182, no. 3, pp. 709-718 . https://doi.org/10.1007/s10549-020-05725-z
Breast Cancer Research and Treatment
Heeg, E, Jensen, M B, Mureau, M A M, Ejlertsen, B, Tollenaar, R A E M, Christiansen, P M & Vrancken Peeters, M T F D 2020, ' Breast-contour preserving procedures for early-stage breast cancer : a population-based study of the trends, variation in practice and predictive characteristics in Denmark and the Netherlands ', Breast Cancer Research and Treatment, vol. 182, no. 3, pp. 709-718 . https://doi.org/10.1007/s10549-020-05725-z
Purpose Breast-contour preservation (BCP) is possible for most women treated for early-stage breast cancer. BCP can be defined as primary breast-conserving treatment (BCT), neoadjuvant chemotherapy (NAC) followed by BCT and immediate postmastectomy b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::38648ffb3e234e8a674854b52cd34809
https://link.springer.com/article/10.1007/s10549-020-05725-z
https://link.springer.com/article/10.1007/s10549-020-05725-z
Autor:
Trine Tramm, Stephen Hamilton-Dutoit, James W. Baurley, Kristina Lystlund Lauridsen, Per Damkier, Anders Kjærsgaard, Peer Christiansen, Lindsay J Collin, Kristina B. Christensen, Maret L. Maliniak, Rebecca A. Silliman, Deirdre Cronin-Fenton, Timothy L. Lash, Michael E. Zwick, Thomas P. Ahern, Bent Ejlertsen, R. Benjamin Isett, Rebecca Nash, Henrik Toft Sørensen
Publikováno v:
Ahern, T P, Collin, L J, Baurley, J W, Kjærsgaard, A, Nash, R, Maliniak, M L, Damkier, P, Zwick, M E, Isett, R B, Christiansen, P M, Ejlertsen, B, Lauridsen, K L, Christensen, K, Silliman, R A, Toft Sørensen, H, Tramm, T, Hamilton-Dutoit, S, Lash, T L & Cronin-Fenton, D 2020, ' Metabolic Pathway Analysis and Effectiveness of Tamoxifen in Danish Breast Cancer Patients ', Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, vol. 29, no. 3, pp. 582-590 . https://doi.org/10.1158/1055-9965.EPI-19-0833
Ahern, T P, Collin, L J, Baurley, J W, Kjærsgaard, A, Nash, R, Maliniak, M L, Damkier, P, Zwick, M E, Isett, R B, Christiansen, P M, Ejlertsen, B, Lauridsen, K L, Christensen, K B, Silliman, R A, Toft Sorensen, H, Tramm, T, Hamilton-Dutoit, S, Lash, T L & Cronin Fenton, D 2020, ' Metabolic pathway analysis and effectiveness of tamoxifen in Danish breast cancer patients ', Cancer Epidemiology, Biomarkers & Prevention, vol. 29, no. 3, pp. 582-590 . https://doi.org/10.1158/1055-9965.EPI-19-0833
Cancer Epidemiol Biomarkers Prev
Ahern, T P, Collin, L J, Baurley, J W, Kjærsgaard, A, Nash, R, Maliniak, M L, Damkier, P, Zwick, M E, Isett, R B, Christiansen, P M, Ejlertsen, B, Lauridsen, K L, Christensen, K B, Silliman, R A, Toft Sorensen, H, Tramm, T, Hamilton-Dutoit, S, Lash, T L & Cronin Fenton, D 2020, ' Metabolic pathway analysis and effectiveness of tamoxifen in Danish breast cancer patients ', Cancer Epidemiology, Biomarkers & Prevention, vol. 29, no. 3, pp. 582-590 . https://doi.org/10.1158/1055-9965.EPI-19-0833
Cancer Epidemiol Biomarkers Prev
Background: Tamoxifen and its metabolites compete with estrogen to occupy the estrogen receptor. The conventional dose of adjuvant tamoxifen overwhelms estrogen in this competition, reducing breast cancer recurrence risk by nearly half. Phase I metab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1801d69fb5cd7b94c2ec62c58bf25321
https://findresearcher.sdu.dk:8443/ws/files/162520147/1055_9965.EPI_19_0833.full.pdf
https://findresearcher.sdu.dk:8443/ws/files/162520147/1055_9965.EPI_19_0833.full.pdf
Autor:
Sinna Pilgaard Ulrichsen, Henrik Toft Sørensen, Lauren E. McCullough, Michael Goodman, Kristina B. Christensen, Kristina Lystlund Lauridsen, Per Damkier, Rami Yacoub, Lance A. Waller, Timothy L. Lash, Thomas P. Ahern, Bent Ejlertsen, Deirdre Cronin-Fenton, Peer Christiansen, Lindsay J Collin, Stephen Hamilton-Dutoit
Publikováno v:
Collin, L J, Ulrichsen, S P, Ahern, T P, Goodman, M, McCullough, L E, Waller, L A, Bang Christensen, K, Damkier, P, Hamilton-Dutoit, S, Lauridsen, K L, Yacoub, R, Christiansen, P M, Ejlertsen, B, Sørensen, H T, Cronin-Fenton, D P & Lash, T L 2020, ' 17β-Hydroxysteroid dehydrogenase 1:2 and breast cancer recurrence : a Danish population-based study ', Acta Oncologica, vol. 59, no. 3, pp. 329-333 . https://doi.org/10.1080/0284186X.2019.1684560
Acta Oncol
Acta Oncol
BACKGROUND: Approximately 20–40% of patients diagnosed with breast cancer will experience a recurrence up to 20 years after their original diagnosis. 17?-hydroxysteroid dehydrogenase 1 and 2 (HSD17B1 and HSD17B2, respectively) regulate intratumoral
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b1221ea8ab1bf3d1024c9bb6d4f0751
https://portal.findresearcher.sdu.dk/da/publications/2ac08303-0b6f-4061-acbe-e409048b9d9c
https://portal.findresearcher.sdu.dk/da/publications/2ac08303-0b6f-4061-acbe-e409048b9d9c
Autor:
Tine Engberg Damsgaard, Peer Christiansen, Jens Overgaard, Anders Husted Madsen, Katrine Rye Hauerslev
Publikováno v:
Hauerslev, K R, Madsen, A H, Overgaard, J, Damsgaard, T E & Christiansen, P 2020, ' Long-term follow-up on shoulder and arm morbidity in patients treated for early breast cancer ', Acta Oncologica, vol. 59, no. 7, pp. 851-858 . https://doi.org/10.1080/0284186X.2020.1745269
Background: A prospective study on shoulder and arm morbidity was conducted in Denmark in 2003–2005. This study demonstrated that sentinel lymph node biopsy was associated with better outcomes than axillary lymph node dissection 18 months after sur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed38346ace872835593ed259ddf0953e
https://pure.au.dk/portal/da/publications/longterm-followup-on-shoulder-and-arm-morbidity-in-patients-treated-for-early-breast-cancer(6322abf1-edcb-44ca-803c-9cf7a0fe5a51).html
https://pure.au.dk/portal/da/publications/longterm-followup-on-shoulder-and-arm-morbidity-in-patients-treated-for-early-breast-cancer(6322abf1-edcb-44ca-803c-9cf7a0fe5a51).html
Autor:
Vibeke Jensen, Peer Christiansen, Giedrius Lelkaitis, Sarah Schulz Nielsen, Marianne Djernes Lautrup, Anne Marie Bak Jylling
Publikováno v:
Breast Cancer (Tokyo, Japan)
Jylling, A M B, Jensen, V, Lelkaitis, G, Christiansen, P, Nielsen, S S & Lautrup, M D 2020, ' Male breast cancer : clinicopathological characterization of a National Danish cohort 1980–2009 ', Breast Cancer, vol. 27, no. 4, pp. 683-695 . https://doi.org/10.1007/s12282-020-01066-3
Jylling, A M B, Jensen, V, Lelkaitis, G, Christiansen, P, Nielsen, S S & Lautrup, M D 2020, ' Male breast cancer : clinicopathological characterization of a National Danish cohort 1980–2009 ', Breast Cancer, vol. 27, no. 4, pp. 683-695 . https://doi.org/10.1007/s12282-020-01066-3
Background To describe relevant pathological parameters of Danish male breast cancer patients (MBCP) diagnosed from 1980 to 2009, and to relate these data to treatment, overall survival (OS) and standardized mortality rate (SMR). Materials and method
Autor:
Trine Tramm, Peer Christiansen, Jens Overgaard, Vibeke Jensen, Tinne Laurberg, Christina D Lyngholm, Jan Alsner
Publikováno v:
Laurberg, T, Alsner, J, Tramm, T, Jensen, V, Lyngholm, C D, Christiansen, P M & Overgaard, J 2017, ' Impact of age, intrinsic subtype and local treatment on long-term local-regional recurrence and breast cancer mortality among low-risk breast cancer patients ', Acta Oncologica, vol. 56, no. 1, pp. 59-67 . https://doi.org/10.1080/0284186X.2016.1246803
Aim: To evaluate the long-term prognostic impact of age, local treatment and intrinsic subtypes on the risk of local-regional recurrence (LRR) and breast cancer mortality among low-risk patients. Material and methods: Cohort study with prospectively
Autor:
Trine Tramm, Peer Christiansen, Anne Bodilsen, Hanne Melgaard Nielsen, Jonas Amstrup Funder, Anne Schmidt Sorensen, Marco Mele, Josephine Bruun
Publikováno v:
Mele, M, Sørensen, A S, Bruun, J, Funder, J A, Tramm, T, Bodilsen, A, Nielsen, H M & Christiansen, P M 2019, ' Inflammatory breast cancer : A review from our experience ', Breast Disease, vol. 38, no. 2, pp. 47-55 . https://doi.org/10.3233/BD-180365
INTRODUCTION: Inflammatory Breast Cancer (IBC) is a distinct and rare type of breast cancer accounting for up to 6% of all breast cancer cases in Europe. The aim of this study was to investigate diagnostic methods, treatments, and outcome after IBC i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c2fde238c6e05cc881054e1f438ab79
https://pure.au.dk/portal/da/publications/inflammatory-breast-cancer(c3af6599-1a4d-4e37-8e81-962726ba1a64).html
https://pure.au.dk/portal/da/publications/inflammatory-breast-cancer(c3af6599-1a4d-4e37-8e81-962726ba1a64).html
Autor:
Per Damkier, Thomas P. Ahern, Stephen Hamilton-Dutoit, Anders Kjærsgaard, Lindsay J Collin, Peer Christiansen, Kristina B. Christensen, Deirdre Cronin-Fenton, Kristina Lystlund Lauridsen, Timothy L. Lash, Henrik Toft Sørensen, Rami Yacoub
Publikováno v:
Collin, L J, Cronin-Fenton, D P, Ahern, T P, Christensen, K B, Damkier, P, Hamilton-Dutoit, S, Kjaersgaard, A, Lauridsen, K L, Yacoub, R, Christiansen, P, Sørensen, H T & Lash, T L 2019, ' Expression of survivin does not appear to influence breast cancer recurrence risk ', Acta Oncologica, vol. 58, no. 2, pp. 154-161 . https://doi.org/10.1080/0284186X.2018.1503419
BACKGROUND: Survivin is an inhibitor of apoptosis, and its expression associates with poor outcomes in multiple cancers. It may be a therapeutic target due to its unique expression in cancer cells.METHODS: We estimated the association between nuclear
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11c5d4567c22bdcc224bb419fa7029e9
https://pure.au.dk/portal/da/publications/expression-of-survivin-does-not-appear-to-influence-breast-cancer-recurrence-risk(8edf1125-b428-4628-b8be-a770a766d5de).html
https://pure.au.dk/portal/da/publications/expression-of-survivin-does-not-appear-to-influence-breast-cancer-recurrence-risk(8edf1125-b428-4628-b8be-a770a766d5de).html